BRCA1 and cancer: None of the current risk-prediction models intended to identify women at an increased risk of developing breast cancer in the absence of a familial predisposition (that is, mainly carriers of pathogenic BRCA1/2 variants) selectively identifies those women at risk of developing an aggressive cancer that, if not prevented, would likely lead to death.